Cypress Medical Products LLC, headquartered in the United States, is a leading player in the medical device industry, specialising in innovative solutions for healthcare professionals. Founded in 2007, the company has established a strong presence across various operational regions, focusing on the development and manufacturing of high-quality medical products. Cypress Medical Products is renowned for its unique offerings, including advanced wound care solutions and specialised medical devices that enhance patient outcomes. The company’s commitment to quality and innovation has positioned it as a trusted partner in the healthcare sector, achieving notable milestones in product development and market expansion. With a reputation for excellence, Cypress Medical Products continues to set industry standards, ensuring that healthcare providers have access to the best tools for patient care.
How does Cypress Medical Products LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Cypress Medical Products LLC's score of 47 is higher than 71% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Cypress Medical Products LLC, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of McKesson Corporation, which may influence its climate commitments and reporting practices. While Cypress Medical Products LLC has not established its own reduction targets or climate pledges, it is important to note that any potential climate initiatives or targets may be inherited from McKesson Corporation. This includes commitments to the Science Based Targets initiative (SBTi) and participation in the Carbon Disclosure Project (CDP), both of which are cascaded from McKesson Corporation at a corporate family level. As of now, without specific emissions data or reduction targets, Cypress Medical Products LLC's climate commitments remain unclear. The company may align with broader industry standards and practices through its relationship with McKesson Corporation, which is actively engaged in sustainability efforts.
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 92,194,000 | 00,000,000 | 000,000,000 | 00,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 
| Scope 2 | 188,912,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 
| Scope 3 | 28,733,000 | 00,000,000 | 00,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 
Cypress Medical Products LLC's Scope 3 emissions, which increased by 19% last year and increased significantly since 2016, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 98% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Cypress Medical Products LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.